or Try an Advanced Search...

    Novartis Stocks List

    Symbol Grade Name % Change
    NTLA F Intellia Therapeutics, Inc. 1.42
    PLRX F Pliant Therapeutics, Inc. 5.51
    PHAR F Pharming Group N.V. 0.00
    INCY D Incyte Corporation 1.26
    RPRX D Royalty Pharma plc -1.22
    ALNY D Alnylam Pharmaceuticals, Inc. 1.34
    ENTA C Enanta Pharmaceuticals, Inc. 9.06
    XOMA C XOMA Corporation -2.59
    NVS B Novartis AG -0.07
    TCRX B TScan Therapeutics, Inc. -1.04
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biotechnology Immune System Infectious Diseases Life Sciences Medicine Pharmaceutical Solid Tumors Amyloid Amyloidosis Antitrypsin Deficiency Biology Biopharmaceutical Biopharmaceutical Products Chemical Compounds Hematologic Malignancies Immunology Liver Disease Metabolism Transthyretin Acne

    Related ETFs - A few ETFs which own one or more of the above listed Novartis stocks.

    Symbol Grade Name Weight
    FLSW C Franklin FTSE Switzerland ETF 12.84
    EWL C iShares MSCI Switzerland Capped Index Fund 12.72
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 7.52
    GERM C ETFMG Treatments Testing and Advancements ETF 6.92
    FBT D First Trust Amex Biotech Index Fund 6.66
    View all Novartis ETFs...
    Compare ETFs
    Compare EWL to FBT Compare FLSW to EWL Compare FLSW to SURI

        Novartis Stocks Recent News

        Date Stock Title
        May 3 NTLA Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
        May 3 ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
        May 3 NVS Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
        May 3 ALNY Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
        May 3 NTLA IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 3 ALNY Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
        May 3 ENTA Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
        May 3 NVS Why selling to Novartis made sense for Mariana
        May 3 ALNY Alnylam Pharmaceuticals Inc (ALNY) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
        May 3 INCY Q1 2024 Insight Enterprises Inc Earnings Call
        May 2 RPRX Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
        May 2 NVS Radiopharma stocks higher as sector welcomes the latest M&A deal
        May 2 ALNY Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2024 Earnings Call Transcript
        May 2 NVS Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
        May 2 ALNY Alnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 TCRX AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 ALNY Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
        May 2 ALNY Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
        May 2 NVS Novartis to buy Mariana Oncology in radiopharmaceutical expansion
        May 2 ALNY Alnylam Pharmaceuticals Non-GAAP EPS of -$0.16 beats by $0.32, revenue of $494.3M beats by $67.44M
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biotechnology Immune System Infectious Diseases Life Sciences Medicine Pharmaceutical Solid Tumors Amyloid Amyloidosis Antitrypsin Deficiency Biology Biopharmaceutical Biopharmaceutical Products Chemical Compounds Hematologic Malignancies Immunology Liver Disease Metabolism Transthyretin Acne
        Novartis

        Browse All Tags